Vaccinex, Inc. Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs
Vaccinex, Inc. (VCNX) had Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs of $696.00 thousand as of 2017-12-31, per its 10-K filed 2019-03-13.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts · last filed 2019-03-13
- 2017-12-31: Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs $696.00K.
| Period end | Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs |
|---|---|
| 2017-12-31 | $696.00K 10-K · filed 2019-03-13 |